Skip to content

NMIN Publication Database

The table below is best viewed in landscape on smaller devices (rotate your phone sideways).

The table below lists publications emerging from  NMIN-supported research projects. It can be searched or sorted by any field. When searching by author, use last name only.

Search
Sort by
AuthorsTitleJournalYear
Terada T, Kulkarni JA, Huynh A, Yi Y, Tam C, Cullis P.

Protective effect of Edaravone against cationic lipid-mediated oxidative stress and apoptosis

Bulletins of the Pharmaceutical Society of Japan

2021
Terada T, Kulkarni JA, Huynh A, Chen S, van der Meel R, Yi Y, Tam C, Cullis PR.

Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiment Approach

Langmuir

2021
Tam A, Leclair P, Li LV, Yang CX, Li X, Witzigmann D, Kulkarni JA, Hackett T-L, Dorscheid DD, Singhera GK, Hogg JC, Cullis PR, Sin DD, Lim CJ

FAM13A as potential therapeutic target in modulating TGF-beta-induced airway tissue 1 remodeling in COPD

American Journal of Physiology-Lung Cellular and Molecular Physiology

2021
Julian Vogler, Roland Bottger, Nojoud AL Fayez, Wunan Zhang, Zhu Qin, Lukas Hohenwarter, Po-Han Chao, Elham Rouhollahi, Nida Bilal, Naliangzi Chen, Brandon Lee, Christine Chen, Brayden Wilkinson, Timonthy Kieffer, Jayesh Kulkarni, Pieter Cullis, Dominik W

Altering the intra-liver distribution of phospholipid-free small unilamellar vesicles using temperature-dependent size-tunability

Journal of Controlled Release

2021
Roy van der Meel, Sam Chen, Josh Zaifman, Jayesh A. Kulkarni, Xu Ran S. Zhang, Ying K. Tam, Marcel B. Bally, Raymond M. Schiffelers, Marco A. Ciufolini, Pieter R. Cullis, and Yuen Yi C. Tam

Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery

Small

2021
Jayesh A. Kulkarni, Sam Chen, and Yuen Yi C. Tam

Scalable Production of Lipid Nanoparticles Containing Amphotericin B

Langmiur

2021
Witzigmann D, Kulkarni JA, Leung J, Chen S, Cullis PR, van der Meel R.

Lipid nanoparticle technology for therapeutic gene regulation in the liver

Advanced Drug Delivery Reviews

2020
Francia V, Schiffelers RM, Cullis PR, Witzigmann D.

The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy

Bioconjugate Chemistry

2020
Kulkarni JA, Thomson SB, Zaifman J, Leung J, Wagner PK, Hill A, Yi Y, Tam C, Cullis PR, Petkaubc TL, Leavitt BR.

Spontaneous, solvent-free entrapment of siRNA within lipid nanoparticles

Nanoscale

2020
Strilchuk AW, Meixner SC, Leung J, Safikhan N, Kulkarni JA, Russell HM, van der Meel R, Sutherland MR, Owens AP, Palumbo J, Conway EM, Pryzdial ELG, Cullis P, Kastrup CJ.

Sustained Depletion of FXIII-A by Inducing Acquired FXIII-B Deficiency

Blood

2020
Hartjes TA, Slotman JA, Vredenbregt MS, Dits N, van der Meel R, Djuivesz D, Kulkarni JA, French PJ, van Cappellen QA, Schiffelers RM, Houtsmuller AB, Jenster GW, van Royen M.

EVQuant; high-throughput quantification and characterization of extracellular vesicle (sub)populations

bioRxiv

2020
Henrickson A, Kulkarni JA, Zaifman J, Gorbet G, Cullis PR, Demeler B.

Density Matching – Multi-Wavelength Analytical Ultracentrifugation to Measure Drug Loading of Lipid Nanoparticle Formulations

ACS Nano

2020
Ul Ain Q, Campos EVR, Huynh A, Witzigmann D, Hedtrich S.

Gene Delivery to the Skin – How Far Have We Come?

Trends in Biotechnology

2020
Akinc A, Maier MA, Manoharan M, Fitzgerald K, Jayaraman M, Barros S, Ansell S, Du X, Hope MJ, Madden TD, Mui BL, Semple SC, Tam YK, Ciufolini M, Witzigmann D, Kulkarni JA, van der Meel R, Cullis PR.

The Onpattro Story and the Clinical Translation of Nanomedicines Containing Nucleic Acid-Based Drugs

Nature Nanotechnology

2019